AMRN$12.114.91%-0.625
Amarin Corp Adr (AMRN)
Date: 2026-10-30 16:00O: 12.71H: 12.76L: 12.00C: 12.11Vol: 101.3k
Amarin Corp Adr stock is traded at $12.11, with a volume of 101,276. It is down -4.91% in the last 24 hours and down -6.85% over the past month. Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.
Previous Close:
$12.74
Open:
$12.71
24h Volume:
101,276
Relative Volume:
1.49
Market Cap:
$255.80M
Revenue:
$217.21M
Net Income/Loss:
-$33.72M
P/E Ratio:
-
EPS:
-$1.62
Net Cash Flow:
$25.63M
1W Performance:
+2.71%
1M Performance:
-6.85%
6M Performance:
-13.07%
1Y Performance:
-26.16%
1-Day Range:
$12.00$12.76
1-Week Range:
$11.70$13.18
52-Week Range:
$11.25$17.31
Amarin Corp Adr Stock (AMRN) Company Profile
Name
Amarin Corp AdrSector
HealthcareIndustry
Drug Manufacturers - GeneralPhone
353 1 6699 020Address
SPACES SOUTH DOCKLANDS, BLOCK C, DUBLIN 2, IrelandCompare AMRN vs LLY, JNJ, ABBV, MRK, NVS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMRN Amarin Corp Adr | $12.11 | $255.80M | $217.21M | -$33.72M | $25.63M | -$1.62 |
 LLY Lilly Eli Co | $1,417.54 | $1.26T | $72.25B | $25.28B | $10.37B | $27.78 |
 JNJ Johnson Johnson | $273.20 | $657.68B | $97.93B | $21.04B | $17.80B | $8.63 |
 ABBV Abbvie Inc | $294.89 | $521.11B | $62.82B | $3.60B | $19.98B | $2.03 |
 MRK Merck Co Inc | $149.52 | $368.89B | $65.51B | $8.93B | $14.12B | $3.55 |
 NVS Novartis Ag Adr | $160.79 | $303.67B | $54.66B | $13.58B | $16.05B | $7.02 |
